Healthier Women, Stronger Societies. A New Initiative with HSPH
Michael's at Shoreline
2960 Shoreline Blvd
Mountain View, CA
(650) 962-1014
$20 members, $40 non-members (lunch included); HSPH alumni at member rate...
Professor Ana Langer, MD, Director and Priva Agrawal, MD, MPH, Acting Director of Research and Development
Healthier Women, Stronger Societies: Advancing the Global Women and Health Agenda
Women and Health Initiative, Harvard School of Public Health
Investments in health and the empowerment of women are investments in social and economic development. To realize the potential of women as drivers of change and full contributors to stronger societies, we must address the most neglected and urgent women's health issues, such as maternal mortality, which far too many women in the world's poorest communities still face today, and move on to focus on the empowerment of women as users and producers of health care.
Drs. Langer and Agrawal will describe the unique mission of the Women and Health Initiative and discuss the innovative tools and approaches they are developing and implementing to address the main challenges in this complex field. Join them to hear about their vision and specific projects.
REGISTER NOW!
Wednesday, September 21st
Noon- 1:30pm (Presentations start at 12:15)
Michael's at Shoreline
2960 Shoreline Blvd
Mountain View, CA
(650) 962-1014
$20 HCSF and HCSV members, $40 non-members (lunch included); HSPH alumni at member rate...
no refunds after Friday, Sept 16th
REGISTER HERE!
Ana Langer, MD, is Professor of the Practice of Public Health in the Department of Global
Health and Population at HSPH. Dr. Langer has been a leading advocate for the improvement of women’s health globally—predominantly in the Latin American and Caribbean regions—through the introduction of evidence-based practices. From 2005 – 2010, Dr. Langer was President and CEO of EngenderHealth, an international not-for-profit organization dedicated to improving sexual and reproductive health for women and men in the poorest communities in over 90 countries. Previously, she served in a leadership capacity with both the Population Council and the Department of Research in Women and Children’s Health (National Institute of Public Health, Mexico), both conducting clinical trials and establishing and directing the Master’s Program in Reproductive Health—the first program of its kind in Latin America. Her primary research interests span the field of reproductive health, including in particular maternal health, unsafe abortion, and the quality of reproductive health services.
 |
|
| |
|
Priya Agrawal, MD MPH is the Acting Director of Research & Development for the Women and Health Initiative. She is an Obstetrician & Gynaecologist and Visiting Scientist from the United Kingdom and is responsible for leading the implementation research agenda for the W&HI; supporting the development and evaluation of healthcare innovations and teaching and mentoring HSPH students. She received her B.A. from Cambridge University, Medical Degree from University of Oxford, M.P.H from the Harvard School of Public Health on a Fulbright Scholarship. She is a PhD candidate at the London School of Hygiene and Tropical Medicine, evaluating the impact of the WHO Safe Childbirth Checklist Program on health worker performance in India. She has worked as Clinical Advisor to the Medical Director at the National Patient Safety Agency, was awarded a grant by Target Ovarian Cancer to complete a feasibility report for the International Cancer Benchmarking Study and was Program Lead for CLASP (Cervical Cancer Association for Screening and Prevention) in Nigeria. In 2008 Dr. Agrawal was appointed as an NIHR Academic Clinical Fellow and was identified as an Emerging Clinical Leader for the National Health Service. In 2010, she received a Wellbeing of Women Research Fellowship Award. Dr. Agrawal is also Senior Advisor to WHO Patient Safety for the
Mother/Baby 7 day mCheck and Chief Medical Advisor to
Jacaranda Health, a social enterprise dedicated to providing affordable, high quality care for low-income women in Kenya as well as a field testing lab for global innovations in safe motherhood.